Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (6)
P 2 (4)
P 4 (1)

Trial Status

Unknown7
Completed5
Recruiting3
Withdrawn2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07023393Not ApplicableWithdrawn

Proprio Spine Measurement Tool

NCT05110833Enrolling By Invitation

Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery

NCT07349602Not ApplicableCompleted

Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approach in One Center.

NCT05610098Recruiting

Gene Expression Profiles in Spinal Tuberculosis.

NCT05098431Not ApplicableWithdrawn

Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery

NCT06460805Not ApplicableRecruiting

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

NCT06451588Phase 2Recruiting

Fecal Microbiota Transplantation in Axial Spondyloarthritis

NCT06072287Unknown

The Living With a Long-Term Condition Study

NCT03793660Completed

Biologic National Registry

NCT04062695Phase 2Unknown

Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

NCT05376189Phase 2UnknownPrimary

Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis

NCT01642706Unknown

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

NCT03064802Unknown

Burst Biologics Spinal Fusion Registry

NCT02873182Not ApplicableUnknown

Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study

NCT00320619Not ApplicableCompleted

Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery

NCT02809781Phase 2UnknownPrimary

A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis

NCT00936143Phase 4CompletedPrimary

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

NCT00081562CompletedPrimary

Genetics of Ankylosing Spondylitis

Showing all 18 trials

Research Network

Activity Timeline